WallStreetZenWallStreetZen

NASDAQ: EYPT
Eyepoint Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

EYPT past revenue growth

How has EYPT's revenue growth performed historically?
Company
11.14%
Industry
148.4%
Market
16.96%
EYPT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
EYPT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
EYPT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

EYPT earnings and revenue history

Current Revenue
$46.0M
Current Earnings
-$70.8M
Current Profit Margin
-153.8%

EYPT Return on Equity

Current Company
-61.5%
Current Industry
-63.5%
Current Market
188%
EYPT's Return on Equity (-61.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when EYPT announces earnings.

EYPT Return on Assets

Current Company
-33.5%
Current Industry
2.9%
EYPT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

EYPT Return on Capital Employed

Current Company
-23.8%
Current Industry
19.5%
EYPT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EYPT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
EYPT$46.02M-$69.00M-$70.80M+58.70%N/A
VRDN$314.00k-$235.32M-$237.73M-48.16%N/A
CGEM$0.00-$166.97M-$153.16M-100.00%N/A
ALXO$0.00-$158.40M-$160.81M-100.00%N/A
TNGX$36.53M-$95.59M-$101.74M+10.33%N/A
View Top Biotech Stocks

EYPT earnings dates

Next earnings date
May 1, 2024

Eyepoint Pharmaceuticals Earnings & Revenue FAQ

What were EYPT's earnings last quarter?

On Invalid Date, Eyepoint Pharmaceuticals (NASDAQ: EYPT) reported Q4 2023 earnings per share (EPS) of -$0.32, up 72.41% year over year. Total Eyepoint Pharmaceuticals earnings for the quarter were -$14.10 million. In the same quarter last year, Eyepoint Pharmaceuticals's earnings per share (EPS) was -$1.16.

If you're new to stock investing, here's how to buy Eyepoint Pharmaceuticals stock.

What was EYPT's earnings growth in the past year?

As of Q2 2024, Eyepoint Pharmaceuticals's earnings has grown year over year. Eyepoint Pharmaceuticals's earnings in the past year totalled -$70.80 million.

What is EYPT's earnings date?

Eyepoint Pharmaceuticals's earnings date is Invalid Date. Add EYPT to your watchlist to be reminded of EYPT's next earnings announcement.

What was EYPT's revenue last quarter?

On Invalid Date, Eyepoint Pharmaceuticals (NASDAQ: EYPT) reported Q4 2023 revenue of $14.03 million up 33.18% year over year. In the same quarter last year, Eyepoint Pharmaceuticals's revenue was $10.53 million.

What was EYPT's revenue growth in the past year?

As of Q2 2024, Eyepoint Pharmaceuticals's revenue has grown 11.14% year over year. This is 137.26 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Eyepoint Pharmaceuticals's revenue in the past year totalled $46.02 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.